In Vitro Activity of Amoxicillin, Clindamycin, Doxycycline, Metronidazole, and Moxifloxacin Against Oral Actinomyces

Journal of Endodontics

Volumn 33, Issue 5, 2007, Pages 557-560

  LeCorn, Demetrick W ^a   Vertucci, Frank J ^a   Rojas, Maria F ^b   Progulske Fox, Ann ^b   Bélanger, Myriam ^b  

^a Center for Molecular Microbiology   (United States)

^b NONE   (United States)

Author keywords

Actinomyces; amoxicillin; clindamycin; doxycycline; metronidazole; moxifloxacin

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT; CLINDAMYCIN; DOXYCYCLINE; HETEROCYCLIC COMPOUND; METRONIDAZOLE; MOXIFLOXACIN; QUINOLINE DERIVATIVE;

ACTINOMYCES; ACTINOMYCOSIS; ARTICLE; DRUG EFFECT; HUMAN; MICROBIOLOGY; TOOTH PERIAPICAL DISEASE;

ACTINOMYCES; ACTINOMYCOSIS; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; AZA COMPOUNDS; CLINDAMYCIN; DOXYCYCLINE; HUMANS; METRONIDAZOLE; PERIAPICAL PERIODONTITIS; QUINOLINES;

EID: 34147137830     PISSN: 00992399     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joen.2007.02.002     Document Type: Article

References (33)

1. O'Grady J.F., and Reade P.C. Periapical actinomycosis involving Actinomyces israelii. J Endod 14 (1988) 147-149
2. Xia T., and Baumgartner J.C. Occurrence of Actinomyces in infections of endodontic origin. J Endod 29 (2003) 549-552
3. Howell Jr. A., Stephan R.M., and Paul F. Prevalence of Actinomyces israelii, A. naeslundii, Bacterionema matruchotii, and Candida albicans in selected areas of the oral cavity and saliva. J Dent Res 41 (1962) 1050-1059
4. Chu F.C.S., Tsang P., Chow T.W., and Samaranayake L.P. Identification of cultivable microorganisms from primary endodontic infections with exposed and unexposed pulp space. J Endod 31 (2005) 424-429
5. Figdor D., and Davies J. Cell surface structures of Actinomyces israelii. Aust Dent J 42 (1997) 125-128
6. Tang G., Samaranayake L.P., Yip H.K., Chu F.C., Tsang P.C., and Cheung B.P. Direct detection of Actinomyces spp. from infected root canals in a Chinese population: a study using PCR-based, oligonucleotide-DNA hybridization technique. J Dent 31 (2003) 559-568
7. de Souza C.A.S., Teles R.P., Souto R., Chaves M.A.E., and Colombo A.P.V. Endodontic therapy associated with calcium hydroxide as an intracanal dressing: microbiologic evaluation by the checkerboard DNA-DNA hybridization technique. J Endod 31 (2005) 79-83
8. Happonen R.P. Periapical actinomycosis: a follow-up study of 16 surgically treated cases. Endod Dent Traumatol 2 (1986) 205-209
9. Sunde P.T., Olsen I., Debelian G.J., and Tronstad L. Microbiota of periapical lesions refractory to endodontic therapy. J Endod 28 (2002) 304-310
10. Byström A., and Sundqvist G. Bacteriologic evaluation of the efficacy of mechanical root canal instrumentation in endodontic therapy. Scand J Dent Res 89 (1981) 321-328
11. Byström A., and Sundqvist G. Bacteriologic evaluation of the effect of 0.5 percent sodium hypochlorite in endodontic therapy. Oral Surg Oral Med Oral Pathol 55 (1983) 307-312
12. Byström A., Claesson R., and Sundqvist G. The antibacterial effect of camphorated paramonochlorophenol, camphorated phenol and calcium hydroxide in the treatment of infected root canals. Endod Dent Traumatol 1 (1985) 170-175
13. Orstavik D., and Haapasalo M. Disinfection by endodontic irrigants and dressings of experimentally infected dentinal tubules. Endod Dent Traumatol 6 (1990) 142-149
14. Cwikla S.J., Bélanger M., Giguère S., Progulske-Fox A., and Vertucci F.J. Dentinal tubule disinfection using three calcium hydroxide formulations. J Endod 31 (2005) 50-52
15. Siqueira Jr. J.F. Aetiology of root canal treatment failure: why well-treated teeth can fail. Int Endod J 34 (2001) 1-10
16. Abbott P.V., Hume W.R., and Pearman J.W. Antibiotics and endodontics. Aust Dent J 35 (1990) 50-60
17. Barnard D., Davies J., and Figdor D. Susceptibility of Actinomyces israelii to antibiotics, sodium hypochlorite and calcium hydroxide. Int Endod J 29 (1996) 320-326
18. Chan Y., and Chan C.H. Antibiotic resistance of pathogenic bacteria from odontogenic infections in Taiwan. J Microbiol Immunol Infect 36 (2003) 105-110
19. Milazzo I., Blandino G., Musumeci R., Nicoletti G., Lo Bue A.M., and Speciale A. Antibacterial activity of moxifloxacin against periodontal anaerobic pathogens involved in systemic infections. Int J Antimicrob Agents 20 (2002) 451-456
20. Behra-Miellet J., Dubreuil L., and Jumas-Bilak E. Antianaerobic activity of moxifloxacin compared with that of ofloxacin, ciprofloxacin, clindamycin, metronidazole and beta-lactams. Int J Antimicrob Agents 20 (2002) 366-374
21. Dalhoff A., Petersen U., and Endermann R. In vitro activity of BAY 12-8039, a new 8-methoxyquinolone. Chemotherapy 42 (1996) 410-425
22. Bauernfeind A. Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin. J Antimicrob Chemother 40 (1997) 639-651
23. Speciale A., Musumeci R., Blandino G., Milazzo I., Caccamo F., and Nicoletti G. Minimal inhibitory concentrations and time-kill determination of moxifloxacin against aerobic and anaerobic isolates. Int J Antimicrob Agents 19 (2002) 111-118
24. Oliphant C.M., and Green G.M. Quinolones: a comprehensive review. Am Fam Physician 65 (2002) 455-464
25. National Committee for Clinical Laboratory Standards (NCCLS). Performance standards for antimicrobial susceptibility testing of anaerobic bacteria; Approved standard-Sixth Edition. Vol. 24, No. 2. Wayne, PA:NCCLS, 2004:M11-A6.
26. Sundqvist G., Figdor D., Persson S., and Sjögren U. Microbiologic analysis of teeth with failed endodontic treatment and the outcome of conservative re-treatment. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85 (1998) 86-93
27. Sundqvist G. Ecology of root canal flora. J Endod 18 (1992) 427-430
28. Grossman L.I. Sterilization of infected root canals. J Am Dent Assoc 85 (1972) 900-905
29. Byström A., Happonen R.P., Sjögren U., and Sundqvist G. Healing of periapical lesions of pulpless teeth after endodontic treatment with controlled asepsis. Endod Dent Traumatol 3 (1987) 58-63
30. Appelbaum P.C., Spangler S.K., and Jacobs M.R. Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centers. Antimicrob Agents Chemother 34 (1990) 1546-1550
31. Smith A.J., Hall V., Thakker B., and Gemmell C.G. Antimicrobial susceptibility testing of Actinomyces species with 12 antimicrobial agents. J Antimicrob Chemother 56 (2005) 407-409
32. Krasemann C., Meyer J., and Tillotson G. Evaluation of the clinical microbiology profile of moxifloxacin. Clin Infect Dis 32 (2001) S51-S63
33. Tang G., Samaranayake L.P., and Yip H.K. Molecular evaluation of residual endodontic microorganisms after instrumentation, irrigation and medication with either calcium hydroxide or Septomixine. Oral Dis 10 (2004) 389-397